-
EP3421039
Procédure d'examen
Extrait du Registre européen des brevets
EP Citations: EP3421039
| Cité dans | Recherche | Type: | Littérature brevet | N° de publication: | WO2015012298
[XY] (ONO PHARMACEUTICAL CO [JP]) [X] 1-8 * paragraphs [0093] , [0105]; claim 1 * [Y] 1-8; | Type: | Littérature brevet | N° de publication: | EP3026045
[P] (ONO PHARMACEUTICAL CO [JP]) [P] * paragraphs [0086] , [0098]; claim 1 *; | Type: | Littérature brevet | N° de publication: | WO2016193680
[YP] (BERGENBIO AS [NO], et al) [YP] 1-8* claim 1 *; | Type: | Littérature non-brevet | Information sur la publication: | [Y] - Gausdal, "Abstract B014: BGB324, a selective small molecule inhibitor of the receptor tyrosine kinase AXL, enhances immune checkpoint inhibitor efficacy | Cancer Immunology Research", Cancer Immunol Res 2016;4(1 Suppl):Abstract nr B014., (20160101), URL: http://cancerimmunolres.aacrjournals.org/content/4/1_Supplement/B014, (20181026), XP055519427 [Y] 1-8 * the whole document * | DOI: | http://dx.doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B014 | Type: | Littérature non-brevet | Information sur la publication: | [A] - P. A. OTT ET AL, "CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients", CLINICAL CANCER RESEARCH, US, (20131001), vol. 19, no. 19, doi:10.1158/1078-0432.CCR-13-0143, ISSN 1078-0432, pages 5300 - 5309, XP055458362 [A] 1-8 * abstract * | DOI: | http://dx.doi.org/10.1158/1078-0432.CCR-13-0143 | Cité dans | Recherche internationale | Type: | Littérature brevet | N° de publication: | WO2015012298
[Y] (ONO PHARMACEUTICAL CO [JP]) [Y] 1-9 * , claims; paragraphs [0085], [0090] to [0093], [0140], [0354] to [0355] & US 2016/0168121 A1 claims; paragraphs [0135], [0140] to [0143], [0202] to [0203], [0714] to [0724] & EP 3026045 A1 & CN 105408312 A & KR 10-2016-0033707 A *; | Type: | Littérature non-brevet | Information sur la publication: | [Y] - GRO GAUSDAL et al., "Abstract B014: BGB324, a selective small molecule inhibitor of the receptor tyrosine kinase AXL, enhances immune checkpoint inhibitor efficacy", Cancer Immunology Research, vol. 4, no. Suppl 1, (20160100), URL: http://cancerimmunolres.aacrjournals.org/content/4/1_Supplement/B014, (20170322), XP055519427 [Y] 1-9 * , Abstract * | DOI: | http://dx.doi.org/10.1158/2326-6074.CRICIMTEATIAACR15-B014 | Type: | Littérature non-brevet | Information sur la publication: | [Y] - KUNIKO SUNAMI, "CTLA-4 o Hyoteki to shita Gan Men'eki Ryoho", Japanese Journal of Clinical Medicine (special extra issue) Saishin Gan Yakubutsu Ryohogaku, (20140220), vol. 72, pages 280 - 285 [Y] 1-9 * , Introduction * | Type: | Littérature non-brevet | Information sur la publication: | [Y] - SHIN FOONG NIGLOW et al., "Anti-TIM3 Antibody Promotes T Cell IFN-y-Mediated Antitumor Immunity and Suppresses Established Tumors", Cancer Research, (20110515), vol. 71, no. 10, pages 3540 - 3551, XP055181433 [Y] 1-9 * , Abstract * | DOI: | http://dx.doi.org/10.1158/0008-5472.CAN-11-0096 | Type: | Littérature non-brevet | Information sur la publication: | [Y] - PASERO CHRISTINE et al., "Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity", Immunology Letters, (20130300), vol. 151, no. 1-2, pages 71 - 75, XP055251710 [Y] 1-9 * , Abstract * | DOI: | http://dx.doi.org/10.1016/j.imlet.2013.01.008 | Type: | Littérature non-brevet | Information sur la publication: | [AP] - YOSHIZAWA TOSHIO et al., "Abstract LB-218: Development of Axl/Mer inhibitor , ONO-9330547: preclinical evidence supporting the combination with immunotherapeutics", Cancer Research, vol. 76, no. 14 S, (20160700), URL: http://cancerres.aacrjournals.org/content/76/14_Supplement/LB-218, (20170322), XP055537320 [AP] 1-9 * , Abstract * | DOI: | http://dx.doi.org/10.1158/1538-7445.AM2016-LB-218 | Cité dans | par le demandeur | Type: | Littérature brevet | N° de publication: | WO2007030680
| Type: | Littérature brevet | N° de publication: | WO2007057399
| Type: | Littérature brevet | N° de publication: | WO2007070872
| Type: | Littérature brevet | N° de publication: | WO2008045978
| Type: | Littérature brevet | N° de publication: | WO2008080134
| Type: | Littérature brevet | N° de publication: | WO2008083356
| Type: | Littérature brevet | N° de publication: | WO2008083353
| Type: | Littérature brevet | N° de publication: | WO2008083354
| Type: | Littérature brevet | N° de publication: | WO2008083367
| Type: | Littérature brevet | N° de publication: | WO2008083357
| Type: | Littérature brevet | N° de publication: | WO2008128072
| Type: | Littérature brevet | N° de publication: | WO2009007390
| Type: | Littérature brevet | N° de publication: | WO2009024825
| Type: | Littérature brevet | N° de publication: | WO2009047514
| Type: | Littérature brevet | N° de publication: | WO2009053737
| Type: | Littérature brevet | N° de publication: | WO2009054864
| Type: | Littérature brevet | N° de publication: | WO2009127417
| Type: | Littérature brevet | N° de publication: | WO2010005876
| Type: | Littérature brevet | N° de publication: | WO2010005879
| Type: | Littérature brevet | N° de publication: | WO2010090764
| Type: | Littérature brevet | N° de publication: | WO2010128659
| Type: | Littérature brevet | N° de publication: | WO2012028332
| Type: | Littérature brevet | N° de publication: | WO2012135800
| Type: | Littérature brevet | N° de publication: | WO2013074633
| Type: | Littérature brevet | N° de publication: | WO2013115280
| Type: | Littérature brevet | N° de publication: | WO2013162061
| Type: | Littérature brevet | N° de publication: | WO2014091265
| Type: | Littérature brevet | N° de publication: | WO2015012298
| Type: | Littérature brevet | N° de publication: | WO2016006706
| Type: | Littérature brevet | N° de publication: | WO2016097918
| Type: | Littérature brevet | N° de publication: | WO2016193680
| Type: | Littérature non-brevet | Information sur la publication: | - Clinical Science, (20120000), vol. 122, pages 361 - 368 | Type: | Littérature non-brevet | Information sur la publication: | - Proceedings of the national academy of sciences of the United States of America, (20100000), vol. 107, no. 3, pages 1124 - 1129 | Type: | Littérature non-brevet | Information sur la publication: | - Blood, (20130000), vol. 121, pages 2064 - 2073 | Type: | Littérature non-brevet | Information sur la publication: | - Nature Reviews Cancer, (20140000), vol. 14, pages 769 - 785 | Type: | Littérature non-brevet | Information sur la publication: | - "Development of Medicaments", Molecular Design, Hirokawa Shoten, (19900000), vol. 7, pages 163 - 198 | Type: | Littérature non-brevet | Information sur la publication: | - Nature Reviews Cancer, vol. 12, pages 252 - 264,2012 | Type: | Littérature non-brevet | Information sur la publication: | - Cancer Cell, (20150000), vol. 27, pages 450 - 461 |